TransMedics (TMDX) Cash from Operations Growth (3y) (2021 - 2026)
TransMedics (TMDX) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 9.30% |
| 10 | TransMedics | 3.22 Bn | 2.75 Bn | 113.20 Mn | 70.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.80% |
| Mar 31, 2026 | 69.07% |
| Dec 31, 2025 | 119.35% |
| Sep 30, 2025 | 90.11% |
| Jun 30, 2025 | 129.41% |
| Mar 31, 2025 | 46.27% |
| Dec 31, 2024 | 70.51% |
| Sep 30, 2024 | 39.82% |
| Jun 30, 2024 | 88.01% |
| Mar 31, 2024 | 22.33% |
| Dec 31, 2023 | 46.80% |
| Sep 30, 2023 | -2.32% |
| Jun 30, 2023 | 12.08% |
| Mar 31, 2023 | -1.94% |
| Dec 31, 2022 | 17.80% |
| Sep 30, 2022 | -36.65% |
| Jun 30, 2022 | 9.23% |
| Mar 31, 2022 | -36.32% |
| Dec 31, 2021 | -2.80% |
| Sep 30, 2021 | -15.53% |